Optimizing Gastrointestinal Care in the Cancer Patient: A Gastroenterologist’s Toolkit

Early recognition and management of precancerous gastrointestinal (GI) disorders are essential to cancer prevention and early detection. As our understanding of the pathogenesis of these conditions evolves, treatment algorithms continue to advance. In parallel, emerging endoscopic techniques play an increasingly critical role—not only in surveillance, diagnosis, and treatment of early-stage disease, but also in the palliative care of patients with advanced GI malignancies.

This one-day course will provide a comprehensive update on the diagnosis, management, and surveillance of precancerous and malignant GI disorders, covering the luminal GI tract, liver, and pancreatobiliary system. Topics will include Barrett’s esophagus, gastric intestinal metaplasia, Helicobacter pylori, pancreatic cysts, and inflammatory bowel disease. The course will also explore endoscopic management of GI malignancies, including the role of EUS, as well as the treatment of luminal obstructions, leaks, fistulas, perforations, and endoscopic submucosal dissection (ESD).

Additional sessions will cover nutrition and GI symptom management, including chemotherapy- and radiation-induced GI toxicity, along with GI and interventional radiology (IR) approaches to managing GI bleeding in cancer patients. Liver-related topics will include the evaluation and treatment of abnormal liver chemistries, management of hepatitis B and C in oncology patients, surgical management for cancer in cirrhotic patients, and IR management of portal hypertension complications.

The program will feature expert-led didactic lectures and interactive, case-based discussions to support practical application of key concepts in clinical practice. Following the conclusion of the program, registrants will receive access to a syllabus that includes PDF versions of faculty presentation slides and recorded session videos.

This course is intended for physicians and healthcare professionals—including gastroenterologists, oncologists, geneticists, pathologists, advanced practice providers, nurses, fellows, and residents—who care for patients with gastrointestinal, liver, and pancreaticobiliary disorders. This program will be held exclusively in person at Memorial Sloan Kettering’s Zuckerman Research Center (a virtual attendance option will not be available.)

1. Recognize the diagnosis and management of immunotherapy related GI complications
2. Describe the role of endoscopy in the surveillance, diagnosis, management and palliation of premalignant and malignant GI disorders
3. Discuss the management of GI bleeding, nutrition and chemotherapy and radiation-induced GI toxicity in the cancer patient
4. Explain the evaluation and management of abnormal liver chemistries, hepatitis B and C infection and portal hypertension related complications in the cancer patient

This course will be offered exclusively in person; a virtual attendance option will not be available.

Registration Fees

• Physicians (MDs, PhDs, DOs) $300

• Advanced Practice Providers: $250

• Nursing and Other Healthcare Professionals: $200

• Residents, Fellows, and Students*: $100

• Industry Professionals**: $525

• MSK Employees: Complimentary

*The registration fee for residents, fellows, and students is non-refundable.
**An “industry professional” is defined as any individual—regardless of profession (e.g., MD, PhD, APP, RN)—who is employed by an ineligible company. View our Registration Policy for Industry Professionals for more information.

Registration Discounts: Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Meals and Accommodations: Continental breakfast, lunch, and refreshment breaks will be provided to attendees. If you have dietary restrictions or require special accommodations to attend in person, please contact us at [email protected] at least one week prior to the course.

Cancellation Policy: For details on our cancellation terms, please review our Cancellation Policy.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This course will offer the following credit types:

• AMA PRA Category 1 Credits™

• American Board of Internal Medicine's (ABIM) Maintenance of Certification

• American Board of Pathology (ABPath) Continuing Certification

• American Board of Surgery (ABS) Continuous Certification

• ANCC Nursing Contact Hours (pending application approval)

We look forward to welcoming you to Memorial Sloan Kettering Cancer Center (MSK).

If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, MSK has negotiated special rates and amenities at select hotels in Manhattan. Click here to view the list of select hotels and additional details on each.

For details on planning your visit to MSK, including travel and parking information, click here. Please note that parking validation is not available for attendees.

If you require any specific accommodations to attend this event in person, please contact [email protected] at least one week in advance.

MSK Course Directors 

Arnold J. Markowitz, MD, FASGE, NYSGEF 
Attending, Gastroenterology, Hepatology & Nutrition Service

Robin Mendelsohn, MD, FASGE, NYSGEF
Associate Attending, Gastroenterology, Hepatology & Nutrition Service
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers

MSK Course Planning Committee

Mark A. Schattner, MD, FASGE, AGAF
Chief, Gastroenterology, Hepatology & Nutrition Service

Natalia Zbib, MD
Fellow, Gastroenterology, Hepatology & Nutrition Service

A complete list of faculty and the full schedule brochure will be available soon.

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.